Sequence Similarity Clusters for the Entities in PDB 3W12

Entity #1 | Chains: E
Insulin receptor domains L1-CR protein, length: 310 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 7 7 12373
95 % 7 7 11920 Flexibility: Low
Max RMSD: 1.4, Avg RMSD: 0.8
PDBFlex
90 % 7 7 11736
70 % 7 7 11076
50 % 7 7 9943
40 % 7 7 8980
30 % 7 7 7595
Entity #2 | Chains: C
monoclonal antibody fab 83-7 fragment - heavy chain protein, length: 116 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 5 5 17980
95 % 5 5 16655 Flexibility: No
Max RMSD: 0.7, Avg RMSD: 0.5
PDBFlex
90 % 5 5 16267
70 % 65 76 587
50 % 592 676 6
40 % 5854 6248 1
30 % 7236 7755 1
Entity #3 | Chains: D
monoclonal antibody fab 83-7 fragment - light chain protein, length: 114 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 5 5 17753
95 % 5 5 16445 Flexibility: No
Max RMSD: 0.7, Avg RMSD: 0.5
PDBFlex
90 % 5 8 10591
70 % 178 223 72
50 % 278 347 17
40 % 322 391 27
30 % 7237 7755 1
Entity #4 | Chains: A
Insulin A chain protein, length: 21 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 223 291 6
95 % 224 297 9 Flexibility: Low
Max RMSD: 4.4, Avg RMSD: 0.9
PDBFlex
90 % 225 299 10
70 % 229 305 12
50 % 229 305 18
40 % 229 305 31
30 % 229 305 53
Entity #5 | Chains: B
Insulin B chain protein, length: 26 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name
100 % 217 267 7
95 % 230 304 8
90 % 230 304 9
70 % 230 307 13
50 % 230 307 19
40 % 230 307 32
30 % 230 307 54
Entity #6 | Chains: F
Insulin receptor alpha-CT peptide protein, length: 16 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4UNU 1 A, B IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
2 5ACM 1 A, B MCG IG LAMBDA CHAIN V-II REGION MGC 9606
3 4QYO 2 B Fv fragment(mAb6D8) light chain 10090
4 2Q20 1 A, B Vk1 O18/O8 germline light chain variable domain 9606
5 1MQK 1 L antibody 7E2 FV fragment, light chain 10090
6 4QY8 2 B Fv fragment(mAb6D8) light chain 10090
7 2I24 1 N New Antigen Receptor PBLA8 variable domain 7801
8 5L6Q 1 A, B H5AL 9606
9 5C2B 2 L 3B4 light chain 9606
10 3T0W 1 A, B immunoglobulin variable lambda domain 9606
11 5ACL 1 A MCG IG LAMBDA CHAIN V-II REGION MGC 9606
12 3T0V 1 A immunoglobulin variable lambda domain 9606
13 1OAQ 2 L LIGHT CHAIN FV, RESIDUES 1-120 10090
14 1DLF 1 L ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
15 1SQ2 2 N novel antigen receptor 7801
16 1J05 1 A, L anti-CEA mAb T84.66, light chain Fv fragment 10090
17 2RHE 1 A BENCE-JONES PROTEIN RHE (LIGHT CHAIN) 9606
18 4QXT 2 B Fv fragment(mAb6D8) light chain 10090
19 1A2Y 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
20 3CDC 1 A, B Light Chain Amyloidogenic 9606
21 3CDF 1 A, B, C, D, E, F IMMUNOGLOBULIN LIGHT CHAIN 9606
22 3DVI 1 A Amyloidogenic light chain variable domain AL-103 9606
23 2DLF 1 L PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S)-KAPPA (LIGHT CHAIN)) FV FRAGMENT (VL DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
24 1EEQ 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
25 3U79 1 A, B, C, D, E, F, G, H Amyloidogenic immunoglobulin light chain protein AL-103 Y32F Y96F, variable domain 9606
26 1UAC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
27 4R3S 2 B FV FRAGMENT(MAB6D8) LIGHT CHAIN 10090
28 1EEU 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
29 4UNV 1 A IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
30 4UT7 2 L BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV LIGHT CHAIN DOMAIN, RESIDUES 1-147 9606
31 6BA5 1 A, C, E, G Variable domain of Light Chain, antibody R11 9606
32 1MFA 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090
33 5IR3 1 A Ig lambda chain V-VI region AR 9606
34 4AJ0 1 A, B, C, D GERMINAL LINE LAMBDA 3 3RCW VARIANT VARIABLE DOMAIN VARIANT OF 3RJL2, RESIDUES 1-107 9606
35 4OB5 2 L 4E10 antibody germline precursor 7 light chain Fv 9606
36 1BWW 1 A, B PROTEIN (IG KAPPA CHAIN V-I REGION REI) IMMUNOGLOBULIN KAPPA LIGHT CHAIN 9606
37 5L8L 2 B New antigen receptor variable domain 168098
38 4AIZ 1 A, C, D V2-17 PROTEIN 9606
39 4AIZ 2 B V2-17 PROTEIN 9606
40 5KVE 2 L ZV-48 Antibody scFv Light Chain 10090
41 4L1H 1 A Ig kappa chain V-I region Rei 9606
42 1VFA 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
43 2D7T 2 L anti polyhydroxybutyrate antibody Fv, light chain residues 1-110 9606
44 3BD3 1 A, B catalytic antibody 10090
45 2OTU 1 A, C, E, G Fv light chain variable domain 10090
46 1EFQ 1 A KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
47 5L8J 2 B New antigen receptor variable domain 168098
48 1T6V 2 N, O novel antigen receptor 7801
49 2E27 1 L anti-ciguatoxin antibody, light chain Fv fragment 10090
50 4N1C 1 A, B immunoglobulin variable light chain domain 9606
51 4AIX 1 A, B, C, D IG LAMBDA CHAIN V-IV REGION BAU 9606
52 1I8K 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
53 4X4Z 1 A, B Herceptin VL domain with F53D mutation 9606
54 1G7J 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
55 1PEW 1 A, B Jto2, a LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN 9606
56 1VFB 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
57 3A6C 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
58 2DQD 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
59 1WTL 1 A, B BENCE-JONES PROTEIN MCG (LIGHT CHAIN) 9606
60 2I25 1 N, O New Antigen Receptor PBLA8 variable domain 7801
61 1G7I 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
62 3A67 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
63 1J1X 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
64 5L8K 2 B New antigen receptor variable domain 168098
65 2DQC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
66 1J1O 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
67 1MVU 1 A Ig kappa-chain VJ-region (Light chain) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
68 4M62 1 L, M GEP2 FV light chain UNP residues 21-129 9606
69 1J1P 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
70 1QAC 1 A, B IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN VARIABLE DOMAIN 9606
71 5AYU 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
72 3A6B 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
73 2DQJ 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
74 1N4X 1 L, M immunoglobulin kappa chain variable region 10090
75 3DVF 1 A Amyloidogenic immunoglobulin light chain protein AL-12 9606
76 1KIQ 1 A MONOCLONAL ANTIBODY D1.3 10090
77 2IMN 1 A IGA-KAPPA MCPC603 FV (LIGHT CHAIN) 10090
78 3B5G 1 A, B AMYLOID LAMBDA 6 LIGHT CHAIN VARIABLE REGION PIP residues 1-111 9606
79 3DUR 1 A, C antibody Fv fragment SAG173-04 variable region fragment (Fv) 10090
80 5T93 1 A, B, C, D ALT-05 immunoglobulin light chain variable domain from light chain amyloidosis patient last residue was not visible on electron density 9606
81 1LVE 1 A LEN, A VARIABLE DOMAIN FROM KAPPA-4 TYPE 9606
82 2IMM 1 A IGA-KAPPA MCPC603 FV (LIGHT CHAIN) 10090
83 6BAN 1 A, C, E, G Variable domain of R11 Light Chain 9606
84 5C9K 1 A, B, C, D, E, F, G, H Amyloid lambda 6 light chain variable region PIP 9606
85 1FGV 1 L H52 FV (LIGHT CHAIN) 9606
86 4LCI 1 L anti canine CD28 antibody, 1C6, light chain 10090
87 1A7N 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
88 1CD0 1 A, B PROTEIN (JTO, A VARIABLE DOMAIN FROM LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN) IMMUNOGLOBULIN VARIABLE DOMAIN 9606
89 4LRN 2 L GEP 1 light chain 9606
90 1EK3 1 A, B KAPPA-4 IMMUNOGLOBULIN LIGHT CHAIN VL KAPPA-4 IMMUNOGLOBULIN LIGHT CHAIN VL, REC 9606
91 2YC1 2 B, E SINGLE CHAIN ANTIBODY FRAGMENT 9004G LIGHT CHAIN 9606
92 1G7H 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
93 1A7O 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
94 1KIR 1 A MONOCLONAL ANTIBODY D1.3 10090
95 2DQE 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
96 1DVF 1 A FV D1.3 IGG1, KAPPA 10090
97 1DVF 3 C FV E5.2 IGG1, KAPPA 10090
98 1G7M 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
99 1OAU 2 L, M, N, O IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
100 1B0W 1 A, B, C BENCE-JONES KAPPA I PROTEIN BRE VARIABLE DOMAIN OF LIGHT CHAIN 9606
101 1A6W 1 L B1-8 FV (LIGHT CHAIN) FV FRAGMENT 10090
102 1A7R 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
103 1WZ1 1 L Ig light chain 10090
104 3UPA 1 A, B kappa light chain variable domain 9606
105 3LVE 1 A LEN KAPPA-IV LIGHT CHAIN DIMER 9606
106 1A7P 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
107 4K3G 1 A, B immunoglobulin lambda variable domain L5(L89S) 9606
108 1XIW 3 C, G immunoglobulin light chain variable region 10090
109 5NGV 3 L anti-human ActRIIB mAb BYM338 light-chain VL 9606
110 1A7Q 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
111 1DSF 1 L ANTICANCER ANTIBODY B1 FV 10090
112 3DUU 1 A, C antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
113 3BJ9 1 1 Immunoglobulin iota chain, Immunoglobulin lambda-like polypeptide 1 Fusion protein consists of Ig domain of VPREB protein and J-fragment of Ig lambda-5 9606
114 1H5B 1 A MURINE T CELL RECEPTOR (TCR) VALPHA DOMAIN C-TERMINAL HEXA-HISTIDINE TAG V-ALPHA DOMAIN VA85.33 (AV11S5-AJ17) 10090
115 1H5B 2 B, D MURINE T CELL RECEPTOR (TCR) VALPHA DOMAIN C-TERMINAL HEXA-HISTIDINE TAG V-ALPHA DOMAIN VA85.33 (AV11S5-AJ17) 10090
116 1H5B 3 C MURINE T CELL RECEPTOR (TCR) VALPHA DOMAIN C-TERMINAL HEXA-HISTIDINE TAG V-ALPHA DOMAIN VA85.33 (AV11S5-AJ17) 10090
117 3LRG 1 A, B anti-huntingtin VL domain anti-huntingtin VL domain 9606
118 1KIP 1 A MONOCLONAL ANTIBODY D1.3 10090
119 6A3W 2 B, E, H, K utomilumab VL 9606
120 5LVE 1 A BENCE-JONES PROTEIN LEN G KAPPA CHAIN V-IV, VARIABLE DOMAIN, LIGHT CHAIN 9606
121 2EIZ 1 A ANTI-LYSOZYME ANTIBODY FV REGION VL FRAGMENT 9606
122 1PW3 1 A, B immunoglobulin lambda chain variable region 9606
123 5JPJ 1 A, B 6aJL2 protein 9606
124 2UZI 2 L ANTI-RAS FV LIGHT CHAIN 9606
125 2I27 1 N, O New Antigen Receptor Ancestral variable domain 7801
126 3T0X 1 A, B Immunoglobulin variable lambda domain M8VLA4(S55P) 9606
127 1UA6 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
128 1IC7 1 L LYSOZYME BINDING IG KAPPA CHAIN 10090
129 1CFV 1 L MONOCLONAL ANTIBODY FV4155 FV FRAGMENT 10090
130 1QP1 1 A, B, C BENCE-JONES KAPPA I ANTIBODY BRE (LIGHT CHAIN) IMMUNOGLOBULIN FRAGMENT, VARIABLE DOMAIN 9606
131 3U7A 1 A Amyloidogenic immunoglobulin light chain protein AL-09 Y32F Y96F, variable domain 9606
132 4UU9 2 B, L MEDI7814 VARIABLE DOMAIN LIGHT CHAIN 9606
133 3MOQ 1 A, B, C, D New antigen receptor variable domain,P3(40) peptide from Amyloid beta A4 protein,New antigen receptor variable domain CHIMERA OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN (RESIDUES 1-87 AND 102-113 FROM UNP Q6X1E6) INSERTED WITH AMYLOID BETA 18-41 (RESIDUES 689-712 FROM UNP P05067) 168098
134 1G7L 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
135 1BFV 1 L FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
136 1IVL 1 A, B IGG-KAPPA M29B FV (LIGHT CHAIN) 10090
137 1A6U 1 L B1-8 FV (LIGHT CHAIN) FV FRAGMENT 10090
138 2DQI 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
139 1BRE 1 A, B, C, D, E, F BENCE-JONES KAPPA I PROTEIN BRE 9606
140 3CX5 11 K, V LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
141 5B8C 1 A, D, G, J Pembrolizumab light chain variable region (PemVL) 9606
142 3DV6 1 A antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
143 1VES 1 A, B New Antigen Receptor variable domain 168098
144 2EKS 1 A ANTI-LYSOZYME ANTIBODY FV REGION VL FRAGMENT 9606
145 3BD5 1 A, B catalytic antibody 10090
146 4XVJ 3 L antibody light chain variable domain 9606
147 1AC6 1 A, B T-CELL RECEPTOR ALPHA VARIABLE DOMAIN 10090
148 1JV5 1 A Ig kappa chain precursor V region anti-blood group A Fv 9606
149 1FVC 1 A, C IGG1-KAPPA 4D5 FV (LIGHT CHAIN) 9606
150 4Z0X 1 A Antibody HC26AM light chain variable domain 9606
151 1IC5 1 L LYSOZYME BINDING IG KAPPA CHAIN 10090
152 2CD0 1 A, B PROTEIN (BENCE-JONES PROTEIN WIL, A VARIABLE DOMAIN FROM LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN) VARIABLE DOMAIN 9606
153 4LAS 2 L Single light chain Variable fragment Light Chain 10090
154 2A9M 1 L, M fluorescein-scfv light chain 9606
155 2YWZ 1 A new antigen receptor variable domain 168098
156 1A6V 1 L, M, N B1-8 FV (LIGHT CHAIN) FV FRAGMENT 10090
157 3DUS 1 A, C antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
158 5NH3 3 L, M anti-human ActRIIB mAb BYM338 Fv light-chain 9606
159 2COQ 1 A new antigen receptor variable domain 168098
160 5GRV 2 K homo-specific diabody light chain 9606
161 2GSG 1 A, C monoclonal antibody light chain variable domain 10090
162 2W0L 1 A, B, C, D V1-22 protein 9606
163 5TBD 2 B, F, G, K Fv fragment (mAb4D1) heavy chain 10090
164 5DHV 2 B, L Anti-Rev Antibody Fab single-chain variable fragment, light chain 9986
165 4LVE 1 A, B LEN KAPPA-IV LIGHT CHAIN DIMER 9606
166 43C9 1 A, C, E, G PROTEIN (IMMUNOGLOBULIN (LIGHT CHAIN)) FV 10090
167 1NMB 2 L FAB NC10 RESOLUTION OF 2.5 ANGSTROMS 10090
168 1I8I 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
169 1OAR 2 L, M, N, O IMMUNOGLOBULING E FV, RESIDUES 1-110 10090
170 1D9K 1 A, E T-CELL RECEPTOR D10 (ALPHA CHAIN) 10090
171 3DV4 1 A antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
172 1I3G 1 L ANTIBODY FV FRAGMENT VL DOMAIN 10090
173 1DL7 1 L PROTEIN (ANTIBODY M3C65 (LIGHT CHAIN)) COMBINED LIGHT AND HEAVY CHAIN VIA (G4S)3 LINKER FV (SINGLE CHAIN) 10090
174 1OCW 2 L IMMUNOGLOBULIN E FV REGION, RESIDUES 1-120 10090
175 1IGM 1 L IGM-KAPPA POT FV (LIGHT CHAIN) 9606
176 5GS1 1 A, M, O, Q light chain 9606
177 2DQG 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
178 2PXY 1 A T cell receptor alpha chain 10090
179 3BDX 1 A, B, C Amyloid lambda 6 light chain variable region PIP (fragment) Residues 1-111 9606
180 43CA 1 A, C, E, G PROTEIN (IMMUNOGLOBULIN (LIGHT CHAIN)) FV 10090
181 2DQH 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
182 2Q1E 1 A, B, C, D Amyloidogenic immunoglobulin light chain protein AL-09 9606
183 3EHB 4 D FV fragment Chain L 10090
184 3HB3 4 D ANTIBODY FV FRAGMENT 10090
185 4FFY 1 L DENV1-E111 single chain variable fragment (light chain) 10090
186 4N1E 1 A, B, C, D, E, F, G, H immunoglobulin variable light chain domain 9606
187 5LBS 3 L, M BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8 SCFV fragment, light chain 9606
188 1AP2 1 A, C MONOCLONAL ANTIBODY C219 LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER FV 10090
189 1IC4 1 L LYSOZYME BINDING IG KAPPA CHAIN 10090
190 3CDY 1 A, B IMMUNOGLOBULIN LIGHT CHAIN 9606
191 4RAV 1 B, D Single-chain Fv, VL 9606
192 5XJ4 3 L durvalumab-VL 9606
193 5LWY 3 L V REGION LIGHT CHAIN 10090
194 1KB9 11 K LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
195 4X4X 2 B, D Human Variable Light Chain of Herceptin 9606
196 2Z8V 2 C, D New antigen receptor variable domain 168098
197 2W0K 1 A, B V1-22 PROTEIN 9606
198 2BFV 1 L FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
199 2IBZ 11 Y Variable Light chain of antibody fragment 10090
200 4K3H 1 A, B, C, D, E, F, G, H Immunoglobulin lambda variable domain L5(L89S) 9606
201 2Z8W 2 C, D New antigen receptor variable domain 168098
202 2OI9 2 B T cell receptor alpha chain 10090
203 4HGM 1 A Shark V-NAR 7797
204 3BD4 1 A, B catalytic antibody 10090
205 1WT5 2 C, D ANTI EGFR ANTIBODY FV REGION VL fragment 9606
206 1JHL 1 L IGG1-KAPPA D11.15 FV (LIGHT CHAIN) 10090
207 4LLV 2 B, D, F, L 4E10 Fv light chain 9606
208 4LAR 2 L Single light chain variable fragment Light Chain 10090
209 5CBA 2 B, D 3b4 light chain 9606
210 1A14 3 L NC10 FV (LIGHT CHAIN) VL DOMAIN OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIVE-RESIDUE POLYPEPTIDE LINKER 10090
211 1C08 1 A ANTI-HEN EGG WHITE LYSOZYME ANTIBODY (HYHEL-10) VL FRAGMENT 10090
212 2OTW 1 A, C Fv light chain avriable domain VL 10090
213 2YSS 1 A ANTI-LYSOZYME ANTIBODY FV REGION VL FRAGMENT 9606
214 2YBR 2 B, E, H SINGLE CHAIN ANTIBODY FRAGMENT 9004G LIGHT CHAIN, RESIDUES 118-263 9606
215 2I26 1 N, O, P New Antigen Receptor Ancestral variable domain 7801
216 2BJM 2 L IGE SPE7 LIGHT CHAIN LIGHT CHAIN, RESIDUES 1-110 10090
217 1P4B 1 L Antibody Variable light chain 10090
218 4Y5V 2 B, E, H Diabody 305 VL domain 9606
219 1I9E 1 A CYTOTOXIC TCELL VALPHA DOMAIN N-TERMINAL DOMAIN OF ALPHA CHAIN 10090
220 1DQL 1 L IGM MEZ IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN FRAGMENT 9606
221 6MTJ 3 E 35O22 scFv light chain portion 9606
222 2Z35 1 A T-cell receptor alpha-chain 10090
223 4X4Y 2 B, D Human Variable Light Chain of Herceptin 9606
224 1VER 1 A New Antigen Receptor variable domain 168098
225 4YQX 2 L, O JES6-1 VL domain 10116
226 1FO0 4 A PROTEIN (BM3.3 T CELL RECEPTOR ALPHA-CHAIN) FV FRAGMENT, VARIABLE DOMAIN 10090
227 1EZV 11 Y LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
228 3U6R 2 B, L Antibody 1:7 (Light chain) 9606
229 1U3H 1 A, E T-cell receptor alpha-chain V2.3-J39-C 10090
230 2YWY 1 A, B, C, D new antigen receptor variable domain 168098
231 1NMC 3 C, L SINGLE CHAIN ANTIBODY VH AND VL DOMAINS OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIFTEEN RESIDUE POLYPEPTIDE LINKER 10090
232 1KB5 1 A KB5-C20 T-CELL ANTIGEN RECEPTOR 24 RESIDUE LINK BETWEEN VALPHA C-TERMINUS AND VBETA N-TERMINUS FV FRAGMENT, VARIABLE DOMAIN 10090
233 2DQF 1 A, D lysozyme binding Ig kappa chain V23-J2 region 10090
234 1B88 1 A, B T CELL RECEPTOR V-ALPHA DOMAIN V-ALPHA DOMAIN 10090
235 6MTN 3 E 35O22 scFv light chain portion 9606
236 3CXH 11 K, V LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
237 6MU7 3 E 35O22 scFv light chain portion 9606
238 2E7L 1 A, B Cytotoxic Tcell receptor UNP RESIDUES 21-132 10090
239 5YOY 2 D, E, F, M, N, O Golimumab light chain variable region 9606
240 2ICW 5 I, K T-cell receptor alpha chain V residues 21-131 10090
241 1P84 11 K Light Chain (Vl) Of Fv-Fragment 10090
242 2XTJ 2 B FAB FROM A HUMAN MONOCLONAL ANTIBODY, 1D05 LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-107 9606
243 5CBE 2 B, D E10 light chain 9606
244 3WXW 3 L V region light chain 10090
245 1F6L 1 L ANTI-FERRITIN IMMUNOGLOBULIN LIGHT CHAIN VARIABLE LIGHT CHAIN 9606
246 3LRH 1 A, C, E, G, I, K, M, O anti-huntingtin VL domain anti-huntingtin VL domain 9606
247 1AR1 4 D ANTIBODY FV FRAGMENT 10090
248 1BVK 1 A, D HULYS11 FV 9606
249 5FV1 1 L, M VK DOMAIN ANTIBODY VK DOMAIN ANTIBODY, RESIDUES 1-108 9606
250 6MU6 3 E 35O22 scFv light chain portion 9606
251 2CJU 2 L NQ16-113.8 ANTI-PHOX ANTIBODY 10090
252 1P4I 1 L ANTIBODY VARIABLE LIGHT CHAIN 10090
253 2LVE 1 A RLEN KAPPA-IV LIGHT CHAIN DIMER 9606
254 2VH5 2 L ANTI-RAS FV LIGHT CHAIN 9606
255 3LH2 3 L, M, N, O Fv 4E10 light chain 9606
256 1OAZ 3 L, N IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
257 1KJ2 4 A, D KB5-C20 T-Cell receptor alpha-chain Fv fragment , variable domain 10090
258 1OAY 2 L, M, N, O IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
259 4LAQ 2 L Single light chain variable fragment Light Chain 10090
260 5LXG 3 L V REGION LIGHT CHAIN 10090
261 4RZC 2 B, D, F, L Fv M6P-1 heavy chain 9986
262 3H3P 2 L, M Fv 4E10 light chain 9606
263 3NN8 2 B, E, F, H Engineered scFv, light chain 10090
264 1OAX 2 L, M, N, O IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
265 4V1D 2 B SINGLE CHAIN ANTIBODY FRAGMENT LR, LIGHT CHAIN 9606
266 4V1D 5 E SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN 9606
267 2Z31 1 A T-cell receptor alpha-chain 10090
268 1NMA 2 L FAB NC10 RESOLUTION OF 3.0 ANGSTROMS 10090
269 1NAM 1 A BM3.3 T Cell Receptor alpha-Chain Fv Fragment, Variable Domain 10090
270 4Y5Y 2 B, E diabody 330 VL domain 9606
271 1BVL 2 B, D HULYS11 FV 10090
272 6CF2 2 B Anti-Rev Antibody, light chain Fab single-chain variable fragment 9986
273 4UNT 1 A, B, C, D, E, F, G, H IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
274 3AB0 3 C, F antibody ScFv fragment, light chain 10090
275 3LHP 2 L, M Fv 4E10 light chain 9606
276 2BX5 1 A, B, C, D, E, F, G, H, I, J, K, L, M, N, O VD9 VKI LIGHT-CHAIN LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-107 9606
277 6CK9 3 E 35O22 scFv light chain portion 9606
278 2UUD 2 K, L NQ10-1.12 ANTI-PHOX ANTIBODY 10090
279 4Y5X 2 B, E, H, K diabody 310 VH domain 9606
280 6MU8 3 E 35O22 scFv light chain portion 9606
281 4UT9 3 L, M, N, O BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10 SCFV, LIGHT CHAIN DOMAIN 9606
282 2A9N 1 L, M fluorescein-scfv light chain 9606
283 5XQY 1 A, B, C, D, E, F, G, H Immunoglobulin kappa variable 1D-33 Y96K mutant of REI VL 9606
284 5GS0 2 C, E light chain (anti-TLR3) 10090
285 5GS0 5 L, Y light chain (anti-Lid) 10090
286 5YY5 3 L Light chain 9606
287 5YY5 5 D Light chain 9606
288 1KYO 11 K, V LIGHT CHAIN (VL) OF FV-FRAGMENT RESIDUES 1-107 10090
289 5GRJ 2 L avelumab L chain 9606
290 4NKD 2 B, D, F, H Engineered scFv light chain 10090
291 6MUG 3 E 35O22 scFv light chain portion 9606
292 3WXV 3 L V region light chain 10090
293 1AR2 1 A REI VARIABLE REGION, LIGHT CHAIN 9606
294 4KV5 3 F, I, K, L light chain GC1009 scFv 9606
295 1QLE 6 L LIGHT CHAIN ANTIBODY FV FRAGMENT 10090
296 3E3Q 3 C, D, I, M, R, V, Z, d T-cell receptor alpha chain V region PHDS58 10090
297 6MUF 3 E 35O22 scFv light chain portion 9606
298 5XP1 1 A, B, C, D, E, F, G, H Immunoglobulin kappa variable 1D-33 UNP residues 22-117 9606
299 5XJ3 2 B, E, H, K ipilimumab-VL 9606
300 4M8Q 2 B, L GEP1 Fv light chain UNP residues 21-129 9606
301 5NHR 1 B, L Bimagrumab Fv Light-Chain VL domain LIGAND BINDING domain 9606
302 5J3H 3 D mAb 83-7 Fab light chain 10090
303 5U8R 3 L Fv 24-60 light chain Light chain variable domain (residues 1-107) of mAb 24-60, including additional Gly at the N terminus. 10090
304 5XWD 3 D VL chain of 059-152 9606
305 4YBQ 2 C, E antibody Fv fragment light chain 10090
306 4PD4 11 K Ig kappa chain V-V region HP 124E1 10090
307 4R0L 3 B, L Antibody 1C6 Light chain UNP residues 20-137 10090
308 5U8Q 4 L Fv 24-60 light chain Light chain variable domain (residues 1-107) of mAb 24-60, including additional Gly at the N terminus. 10090
309 4ODX 3 B, L GEP7 Fv light chain 9606
310 3E2H 3 B T-cell receptor alpha chain V region PHDS58 10090
311 4H1L 4 G, I Ani2.3 TCR A chain 562
312 1RVF 5 L FAB 17-IA 10090
313 5JZ7 3 D, I, K, L MEDI578 scFv, light chain 9606
314 5DHY 2 B, L Anti-Rev Antibody Fab single-chain variable fragment, light chain 9986
315 1QFW 3 L ANTIBODY (ANTI ALPHA SUBUNIT) (LIGHT CHAIN) FV 10090
316 1QFW 5 M ANTIBODY (ANTI BETA SUBUNIT) (LIGHT CHAIN) FV 10090
317 4OGA 4 D monoclonal antibody fab 83-7 fragment - light chain 10090
318 4NKM 2 B, D, F, H Engineered scFv light chain 10090
319 3W11 4 D monoclonal antibody fab 83-7 fragment - light chain 10090
320 4NKO 1 A, C, E Engineered scFv light chain 10090
321 3W13 3 D monoclonal antibody fab 83-7 fragment - light chain 10090
322 3W12 3 D monoclonal antibody fab 83-7 fragment - light chain 10090
323 5DHZ 2 L Anti-Rev Antibody Fab single-chain variable fragment, light chain 9986
324 2A0L 2 C, E 33H1 Fv fragment Fv fragment,light chain 10090
325 5WDU 3 E, P, X bnAb NIH45-46 scFv light chain 9606
326 6MID 4 L monoclonal antibody ZIKV-195 light chain Fab variable domain 9606
327 6IDI 4 J, L, N Fab 1H10 light chain (V-region) 9606
328 6IDK 4 J, L, N Fab 1H10 light chain (V-region) 9606
329 6IDL 4 J, N Fab 1H10 light chain (V-region) 9606
330 6MF7 3 L antibody 860-55D light chain Fab 9606
331 6AJ7 1 L VL of Fab 15C5 10090
332 6AJ9 1 E VL of Fab 11G1 10090
333 6AJ9 3 L VL of Fab 15C5 10090
334 6AD0 1 L VL of Fab 2G8 10090
335 6DZL 3 J, K, L Fv domain of ADI-15878 Fab light chain 9606
336 6DZM 3 H, K, L Antibody ADI-15878 Fab, light chain 9606
337 6GV4 6 L AT12-015 antibody variable light polypeptide chain 9606
338 6CUE 4 4, L, l vFP7.04 light chain 10090
339 6CUE 6 6, N, n PGT122 Light chain 9606
340 6CUE 8 8, R, r VRC03 light chain 9606
341 6CUF 4 6, N, n PGT122 light chain 9606
342 6CUF 5 7, R, r VRC03 light chain 9606
343 6CDI 3 6, N, n PGT122 Light Chain 9606
344 6CDI 5 7, R, r VRC03 light chain 9606
345 6BSP 2 B U4 Light chain 10090
346 5Y0A 3 E, G, L variable region of Fab ZKA190 light chain 9606
347 5XS7 1 L Light chain of Fab 1D5 10090
348 5W3L 6 G C5 antibody variable light domain 10090
349 5W3M 2 G C5 antibody variable light domain 10090
350 5W3O 2 E C5 antibody variable light domain 10090
351 5W3E 2 G C5 antibody variable light domain 10090
352 5TR1 3 L, M Monoclonal antibody, Fab fragment, light chain 10090
353 5TQQ 2 L, M Monoclonal antibody, Fab fragment, light chain 10090
354 5H32 3 H, L, M C10 IgG light chain variable region 9606
355 5H37 4 H, L, M C10 IgG light chain variable region 9606
356 5H30 4 H, L, M IgG C10 light chain 9606
357 5KEL 4 L, T, U c2G4 variable Fab domain light chain 9606
358 5KEL 6 D, N, O c13C6 variable Fab domain light chain 9606
359 5KEM 1 C, H BDBV91 variable Fab domain light chain 9606
360 5KEM 4 E, J c13C6 variable Fab domain light chain 9606
361 5KEN 4 D, H, O c4G7 variable Fab domain light chain 9606
362 5KEN 5 I, P c13C6 variable Fab domain light chain 9606
363 3JCX 3 L Fab E light chain 10116
364 3JBA 1 L H16.U4 antibody light chain Fab variable domain 10090
365 3JAU 3 L Light chain of Fab fragment variable region of antibody D5 10090
366 5A1Z 4 H, J, L ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - LIGHT CHAIN 180 COPIES OF FAB 2D22 MOLECULE BIND TO VIRUS SURFACE 9606
367 4UIF 4 H, J, L ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - LIGHT CHAIN 9606
368 4UIH 3 E, G ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 -LIGHT CHAIN 9606
369 4UDF 3 10, 14, 18, 1C, 1G, 1K, 1O, 1S, 1W, 20, 24, 28, 2C, 2G, 2K, 2O, 2S, 2W, 30, 34, 38, 3C, 3G, 3K, 3O, 3S, 3W, 40, 44, 48, 4C, 4G, 4K, 4O, 4S, 4W, 50, 54, 58, 5C, 5G, 5K, 5O, 5S, 5W, 60, 64, 68, 6C, 6G, 6K, 6O, 6S, 6W, 7C, 7G, 7K, 7O, 7S, 7W HUMAN MONOCLONAL ANTIBODY 9606
370 3J8Z 2 J, K, L, M H16.1A light chain variable domain Fab 10090
371 3J8V 2 J, K, L, M H16.14J light chain variable domain Fab 10090
372 3J8W 1 J, K, L, M H263.A2 light chain variable domain Fab 10090
373 3J7E 1 A, C, E, L H16.V5 Fab light chain variable domain 10090
374 3J6U 4 L Fab 5J7 light chain variable region 9606
375 2MMX 1 A V1-22 protein 9606
376 2MKW 1 A V1-22 protein 9606
377 4CKD 3 L, M, N, O SCFV13R4 ANTIBODY FV LIGHT CHAIN 10090
378 2KQM 1 A, B Ig kappa chain V-I region AU Immunoglobulin kappa light chain 9606
379 2KQN 1 A, B Ig kappa chain V-I region AU Immunoglobulin kappa light chain 9606
380 3IY1 1 A Fab B, light chain antibody B fragment 10116
381 3IY2 1 A Antibody 6, light chain fragment of antibody 6 10090
382 3IY3 1 A antibody fragment from neutralizing antibody 8 (light chain) FAb 8 10090
383 3IY4 1 A fragment of neutralizing antibody 15 (light chain) fragment of neutralizing antibody 15 10090
384 3IY5 1 A antibody fragment IGG2A (light chain) Fab 10090
385 3IY6 1 A fragment from neutralizing antibody E (light chain) FAb E 10116
386 3IY7 1 A fragment from neutralizing antibody F (light chain) FAb F 10116
387 3IY0 1 L Fab 14, light domain Fab14 10090
388 1QNZ 2 L 0.5B ANTIBODY (LIGHT CHAIN) FV 10090
389 1MAJ 1 A IGG2A-KAPPA 26-10 FV (LIGHT CHAIN) 10090
390 1MAK 1 A IGG2A-KAPPA 26-10 FV (LIGHT CHAIN) 10090
391 1REI 1 A, B BENCE-JONES PROTEIN REI (LIGHT CHAIN) 9606